| Biomarkers for tau pathology |
40 |
| Mitochondria' dynamics and transport in Alzheimer's disease |
25 |
| Regulation of actin dynamics during structural plasticity of dendritic spines: Signaling messengers and actin-binding proteins |
23 |
| Small molecules as therapeutic drugs for Alzheimer's disease |
18 |
| Centella asiatica attenuates hippocampal mitochondrial dysfunction and improves memory and executive function in beta-amyloid overexpressing mice |
14 |
| Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson's disease |
13 |
| Functional organization of postsynaptic glutamate receptors |
13 |
| Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease |
12 |
| The genetic architecture of schizophrenia, bipolar disorder, obsessive-compulsive disorder and autism spectrum disorder |
11 |
| Trans epsilon-viniferin is an amyloid-beta disaggregating and anti-inflammatory drug in a mouse primary cellular model of Alzheimer's disease |
11 |
| Taxifolin protects neurons against ischemic injury in vitro via the activation of antioxidant systems and signal transduction pathways of GABAergic neurons |
11 |
| The functional architecture of axonal actin |
10 |
| Synaptic vesicle protein 2A as a potential biomarker in synaptopathies |
10 |
| The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice |
10 |
| Glial mitochondrial function and dysfunction in health and neurodegeneration |
10 |
| Mechanisms of neurotrophin trafficking via Trk receptors |
9 |
| EphBs and ephrin-Bs: Trans-synaptic organizers of synapse development and function |
9 |
| Neural progenitors derived from Tuberous Sclerosis Complex patients exhibit attenuated PI3K/AKT signaling and delayed neuronal differentiation |
9 |
| miR-302/367-induced neurons reduce behavioral impairment in an experimental model of Alzheimer's disease |
9 |
| Munc18-1 haploinsufficiency impairs learning and memory by reduced synaptic vesicular release in a model of Ohtahara syndrome |
9 |
| Peroxisomes contribute to oxidative stress in neurons during doxorubicin-based chemotherapy |
8 |
| Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein |
8 |
| Prefrontal cortical parvalbumin and somatostatin expression and cell density increase during adolescence and are modified by BDNF and sex |
8 |
| Brain microvascular endothelial-astrocyte cell responses following Japanese encephalitis virus infection in an in vitro human blood-brain barrier model |
8 |
| The role of ISWI chromatin remodeling complexes in brain development and neurodevelopmental disorders |
8 |
| Review: Fluid biomarkers in the human prion diseases |
7 |
| Species-conserved SYNGAP1 phenotypes associated with neurodevelopmental disorders |
7 |
| Norepinephrine control of ventromedial hypothalamic nucleus glucoregulatory neurotransmitter expression in the female rat: Role of monocarboxylate transporter function |
7 |
| Cyclo(His-Pro) inhibits NLRP3 inflammasome cascade in ALS microglial cells |
7 |
| Neuron-specific alternative splicing of transcriptional machineries: Implications for neurodevelopmental disorders |
7 |
| Chromatin remodeling and epigenetic regulation of oligodendrocyte myelination and myelin repair |
7 |
| An FTLD-associated SQSTM1 variant impacts Nrf2 and NF-kappa B signalling and is associated with reduced phosphorylation of p62 |
6 |
| Metabotropic glutamate receptor trafficking |
6 |
| AMPA receptor complex constituents: Control of receptor assembly, membrane trafficking and subcellular localization |
6 |
| Exercise decreases BACE and APP levels in the hippocampus of a rat model of Alzheimer's disease |
6 |
| Heat shock protein 70 suppresses neuroinflammation induced by alpha-synuclein in astrocytes |
6 |
| Perturbations in the p53/miR-34a/SIRT1 pathway in the R6/2 Huntington's disease model |
6 |
| Exosome-associated tau exacerbates brain functional impairments induced by traumatic brain injury in mice |
6 |
| TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration |
6 |
| Deletion of the endogenous TrkB.T1 receptor isoform restores the number of hippocampal CA1 parvalbumin-positive neurons and rescues long-term potentiation in pre-symptomatic mSOD1(G93A) ALS mice |
6 |
| Emerging themes in neuronal activity-dependent gene expression |
6 |
| Brain-region specific responses of astrocytes to an in vitro injury and neurotrophins |
6 |
| Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-beta in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice |
6 |
| New insights on Parkinson's disease from differentiation of SH-SY5Y into dopaminergic neurons: An involvement of aquaporin4 and 9 |
5 |
| Characterization of calcium signals in human induced pluripotent stem cell-derived dentate gyrus neuronal progenitors and mature neurons, stably expressing an advanced calcium indicator protein |
5 |
| Cerebrospinal fluid biomarker for Parkinson's disease: An overview |
5 |
| Biomarkers for diseases with TDP-43 pathology |
5 |
| Ginkgolic acid promotes autophagy-dependent clearance of intracellular alpha-synuclein aggregates |
5 |
| Fibroblast growth Factor-21 promotes ketone body utilization in neurons through activation of AMP-dependent kinase |
5 |
| Activation of WNT and CREB signaling pathways in human neuronal cells in response to the Omega-3 fatty acid docosahexaenoic acid (DHA) |
5 |
